ADVANTAGE 40 MG SPOT-ON SOLUTION FOR SMALL CATS AND SMALL PET RABBITS
Riik: Iirimaa
keel: inglise
Allikas: HPRA (Health Products Regulatory Authority)
Toote omadused
(SPC)
12-11-2016
Mõned selle toote dokumendid pole praegu saadaval. Võite saata päringu meie klienditeenindusele ja me teavitame teid sellest niipea, kui meil on neid võimalik hankida.
Saada päring.
Saada päring.
Toimeaine:
IMIDACLOPRID
Saadav alates:
Bayer Limited
ATC kood:
QP53AX17
INN (Rahvusvaheline Nimetus):
IMIDACLOPRID
Annus:
40 Milligram
Ravimvorm:
Spot On Solution
Retsepti tüüp:
POM
Terapeutiline rühm:
Feline, Rabbits
Terapeutiline ala:
Imidacloprid
Näidustused:
Ectoparasiticide
Volitamisolek:
Authorised
Loa andmise kuupäev:
2012-02-24
Toote omadused
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Advantage 40 mg Spot-on solution for Small Cats and Small Pet Rabbits
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each 0.4 ml pipette contains:
ACTIVE SUBSTANCE:
Imidacloprid 40 mg
EXCIPIENT(S):
Butylhydroxytoluene (E 321)
0.4 mg
Benzyl alcohol (E 1519)
332.8 mg
For the full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Spot-on solution
Clear yellow to slightly brownish solution
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cats and pet rabbits
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For cats of less than 4 kg:
Prevention and treatment of flea _(Ctenocephalides felis) _infestations
For pet rabbits of less than 4 kg:
Treatment of flea infestations
Fleas are killed within one day following treatment. One treatment prevents further flea infestation for three to four
weeks on cats and up to one week on pet rabbits. The product can be used as part of a treatment strategy for the control
of Flea Allergy Dermatitis (FAD) in cats, where this has been previously diagnosed by a veterinary surgeon.
4.3 CONTRAINDICATIONS
Do not treat unweaned kittens of less than 8 weeks of age.
Do not use on pet rabbits of less than 10 weeks of age.
Do not use in case of hypersensitivity to the active substance or to any of the excipients.
HEALTH PRODUCTS REGULATORY AUTHORITY
________________________________________________________________________________________________________________________
_Date Printed 28/10/2016_
_CRN 7023723_
_page number: 1_
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
Re-infestation from emergence of new fleas in the environment may continue to occur for six weeks or longer after
treatment is initiated. More than one treatment may therefore be required, depending on the level of fleas in t
Lugege kogu dokumenti
